查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949546

醫療保健檢測服務市場 - 全球產業規模、佔有率、趨勢、機會及預測（按服務類型、產品類型、發展階段、最終用戶、地區和競爭格局分類，2021-2031年）

Healthcare Testing Services Market - Global Industry Size, Share, Trends, Opportunity, & Forecast Segmented By Service Type, By Product Type, By Development Stage, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球醫療檢測服務市場預計將從 2025 年的 64.6 億美元成長到 2031 年的 90.1 億美元，複合年成長率為 5.71%。

該領域涵蓋醫療設備和製藥公司用於確保從研發到生產的整個流程中符合監管要求、產品安全和品質的生物分析和分析測試解決方案。市場成長趨勢的主要驅動力是藥物分子（尤其是生物製藥）日益複雜，以及為降低營運成本而轉向外包的策略轉變。此外，日益嚴格的監管審查也是重要的成長引擎，迫使製造商滿足嚴格的品質標準。美國食品藥物管理局(FDA) 的《2024 年藥品品質狀況報告》也強調了這一點，該報告預測 2024 會計年度將進行 989 項藥品品質保證測試，比上年度成長 27%。

市場概覽
預測期 2027-2031
市場規模：2025年 64.6億美元
市場規模：2031年 90.1億美元
複合年成長率：2026-2031年 5.71%
成長最快的細分市場 化學測試
最大的市場 北美洲

然而，市場面臨著管理複雜調查方法所需的專業人才短缺的嚴峻挑戰。能夠操作先進設備並解讀複雜資料集的合格分析師人才儲備有限，這給服務供應商造成了營運瓶頸，並導致人事費用上升。此外，維護認證實驗室所需的大量資本投入進一步加劇了人才短缺問題，這可能會限制業務擴充性，並嚴重阻礙全球醫療檢測行業的全面擴張。

市場促進因素

全球慢性病和感染疾病的日益普及是全球醫療檢測服務市場的主要驅動力。糖尿病、癌症和結核病等複雜疾病發病率的上升，促使公共衛生機構和製藥公司對各種生物分析支持和診斷測試的需求不斷成長，以加速治療方法的研發。對於感染疾病，這種需求尤其迫切，因為快速監測和檢測對於控制疫情傳播和保護患者健康至關重要。世界衛生組織（世衛組織）在2024年10月發布的《2024年全球結核病報告》中指出，2023年全球將新增約820萬例結核病病例，這將是自1995年全球進行結核病監測以來的最高數字。日益加重的疾病負擔直接導致上市後監測和檢驗新治療方法所需的臨床試驗檢測增加。

同時，生物製藥和生物相似藥開發平臺的不斷擴展正在改變檢測服務產業的格局。與傳統的小分子藥物不同，單株抗體和細胞療法等大分子治療藥物需要高度專業化、靈敏且昂貴的調查方法來評估其效力、純度和免疫抗原性。這種轉變迫使製造商將這些複雜的檢測工作外包給配備先進設備的認證檢測實驗室。根據美國藥物化學及相關技術協會 (DCAT) 於 2024 年 7 月發布的《創新記分卡》，美國 FDA 將在 2023 年核准17 種新的治療性生技藥品，佔所有新藥核准的 31%。這凸顯了該產業向複雜分子藥物研發的重大轉變。領先服務供應商的業績也反映了這一領域的經濟影響。根據 Eurofins Scientific 於 2024 年 2 月發布的“2023 年全年業績報告”，該公司報告總收入為 65.15 億歐元，反映出工業界對外包分析測試活動的持續需求。

市場挑戰

全球醫療檢測服務市場發展面臨的主要障礙之一是專業技術人員短缺。隨著醫療設備和製藥公司對先進生物分析和分析檢測的需求不斷成長，他們面臨著能夠操作這些先進技術的合格分析師嚴重短缺的問題。這種人才短缺導致營運效率下降，例如檢體處理能力降低和交貨時間延長。因此，服務供應商被迫限制新客戶的接收並推遲計劃進度，直接抑制了收入成長和市場擴張。

此外，招募和留住專業人員的高昂成本給實驗室帶來了日益沉重的財務負擔。近期行業統計也印證了這項勞動力短缺問題。根據美國臨床病理學會2024年的職缺調查，病理科的職缺率已高達28.5%，凸顯了此關鍵檢測領域勞動力短缺的嚴重性。如此高的職缺率阻礙了實驗室充分利用其先進的基礎設施和設備。如果沒有足夠的人員來支援業務擴張，檢測服務提供者將無法滿足不斷成長的全球需求，從而有效地阻礙整個醫療檢測行業的發展。

市場趨勢

人工智慧 (AI) 的整合應用正在革新檢查室工作流程，透過自動化複雜的影像分析和改進臨床決策，提高診斷準確性。檢查室擴大部署機器學習演算法來處理海量的病理學和放射學資料集，從而減少人為錯誤並識別傳統方法常常遺漏的細微生物標記。這項技術變革正在加速智慧診斷工具的商業性化應用，並加快基於軟體的醫療解決方案的監管核准流程。根據 MedTech Dive 雜誌 2024 年 10 月號一篇報導「過去十年人工智慧醫療設備數量激增」的文章，美國食品藥物管理局(FDA) 在 2023 年核准了221 種人工智慧或機器學習驅動的醫療設備，這標誌著這些技術在臨床應用中的檢驗顯著增加。

同時，基因組學和精準醫療檢測服務的蓬勃發展正將診斷的重點從廣泛篩檢轉向個人化患者分析。與評估藥物特性的標準生物分析檢測不同，這種轉變強調識別遺傳風險，並指導針對特定患者的標靶治療，尤其是在周產期護理和腫瘤學領域。為此，服務供應商正在擴展其服務範圍，納入能夠提供更深入的臨床見解並支援個人化治療策略的先進分子診斷技術。這種強勁的需求也反映在近期的財務表現中。 Quest Diagnostics 在 2024 年 2 月發布的「2023 會計年度第四季及全年」報告中宣布，其營收實現了兩位數成長，尤其是在包括遺傳疾病檢測和產前檢測在內的先進臨床領域，凸顯了市場對專業精準檢測日益成長的需求。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球醫療保健檢測服務市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按服務項目（化學測試、微生物測試、毒性測試、穩定性測試等）
    • 依產品類型（抗病毒藥物、HIV藥物、生育藥物、抗糖尿病藥物、呼吸系統藥物、抗凝血劑、醫療設備、藥品包裝、其他）
    • 依研發階段（非臨床、臨床、生產）
    • 依最終用戶（製藥業、合約研究機構、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美醫療保健實驗室服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲醫療保健實驗室服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區醫療保健實驗室服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲醫療保健實驗室服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲醫療保健實驗室服務市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球醫療保健實驗室服務市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Eurofins Scientific（Ireland）Limited
  • Thermo Fisher Scientific Inc.
  • Microbac Laboratories, Inc.
  • ARL Bio Pharma, Inc.
  • EM Topco Limited
  • Intertek Group plc
  • Moderna, Inc.
  • ZYUS Life Sciences Corp
  • Alcami Corporation
  • F. Hoffmann-La Roche Ltd

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24329

The Global Healthcare Testing Services Market is projected to expand from USD 6.46 Billion in 2025 to USD 9.01 Billion by 2031, reflecting a CAGR of 5.71%. This sector comprises bioanalytical and analytical testing solutions that medical device manufacturers and pharmaceutical companies utilize to guarantee regulatory compliance, product safety, and quality across the development and manufacturing spectrum. The market's upward trajectory is largely influenced by the growing intricacy of drug molecules, particularly biologics, alongside a strategic pivot toward outsourcing to lower operational expenses. Furthermore, intensified regulatory oversight serves as a crucial growth engine, forcing manufacturers to meet stringent quality benchmarks. This is evidenced by the U.S. Food and Drug Administration's FY2024 Report on the State of Pharmaceutical Quality, which noted 989 drug quality assurance inspections in fiscal year 2024, representing a 27% rise from the prior year.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 6.46 Billion
Market Size 2031USD 9.01 Billion
CAGR 2026-20315.71%
Fastest Growing SegmentChemical Testing
Largest MarketNorth America

However, the market encounters a substantial challenge regarding the scarcity of skilled professionals required to manage complex testing methodologies. The limited pool of qualified analysts capable of operating advanced instrumentation and interpreting intricate data sets creates operational bottlenecks and increases labor costs for service providers. This talent gap, exacerbated by the substantial capital investment needed to maintain accredited laboratories, restricts the scalability of operations and could significantly impede the broader expansion of the global healthcare testing sector.

Market Driver

The escalating global prevalence of chronic and infectious diseases acts as a major engine driving the Global Healthcare Testing Services Market. With the rising incidence of complex conditions like diabetes, cancer, and tuberculosis, public health entities and pharmaceutical firms are increasing their requirements for extensive bioanalytical support and diagnostic testing to speed up treatment creation. This necessity is especially urgent for infectious diseases, where rapid surveillance and detection are essential for controlling outbreaks and protecting patient health. As highlighted in the World Health Organization's 'Global Tuberculosis Report 2024' from October 2024, roughly 8.2 million individuals were newly diagnosed with tuberculosis in 2023, marking the highest figure since global monitoring started in 1995. This growing disease burden leads directly to higher volumes of post-market surveillance studies and clinical trial testing needed to verify new therapeutic solutions.

Concurrently, the expansion of R&D pipelines for biologics and biosimilars is transforming the testing services landscape. In contrast to conventional small-molecule drugs, large-molecule therapies such as monoclonal antibodies and cell therapies require highly specialized, sensitive, and expensive analytical testing methodologies to characterize their potency, purity, and immunogenicity. This shift forces manufacturers to outsource these intricate functions to accredited laboratories equipped with advanced instrumentation. According to the Drug, Chemical & Associated Technologies Association, July 2024, in the 'Innovation Scorecard', the U.S. FDA approved 17 new therapeutic biologics in 2023, which represented 31% of all new drug approvals, highlighting the industry's decisive pivot toward complex molecules. The financial magnitude of this sector is evident in the performance of leading service providers; according to Eurofins Scientific, February 2024, in the '2023 Full Year Results', the company reported total revenues of €6,515 million, reflecting the sustained industrial demand for outsourced analytical testing operations.

Market Challenge

A significant barrier impeding the progress of the Global Healthcare Testing Services Market is the shortage of skilled professionals. With medical device and pharmaceutical companies demanding increasingly sophisticated bioanalytical and analytical testing, the sector encounters a severe lack of qualified analysts equipped to handle these advanced techniques. This workforce gap results in operational inefficiencies, such as diminished sample processing capabilities and prolonged turnaround times. Consequently, service providers are compelled to restrict new client acceptance and push back project schedules, which directly inhibits revenue growth and market expansion initiatives.

Moreover, the substantial expense associated with hiring and keeping specialized personnel adds to the financial strain on testing laboratories. This labor constraint is supported by recent industry statistics. The American Society for Clinical Pathology's 2024 Vacancy Survey revealed that anatomic pathology departments experienced a vacancy rate of 28.5 percent, highlighting the acuteness of the labor shortage in essential testing domains. Such elevated vacancy rates hinder laboratories from maximizing the potential of their advanced infrastructure and instrumentation. Without an adequate workforce to facilitate operational scaling, testing service providers are unable to satisfy the growing global demand, effectively halting the broader advancement of the healthcare testing industry.

Market Trends

The Integration of Artificial Intelligence for Enhanced Diagnostic Precision is revolutionizing laboratory workflows by automating complex image analysis and improving clinical decision-making. Laboratories are increasingly deploying machine learning algorithms to process vast datasets in pathology and radiology, thereby reducing human error and identifying subtle biomarkers that traditional methods might miss. This technological shift is accelerating the commercial availability of smart diagnostic tools and facilitating faster regulatory clearances for software-based medical solutions. According to MedTech Dive, October 2024, in the article 'The number of AI medical devices has spiked in the past decade', the U.S. Food and Drug Administration authorized 221 AI or machine learning-enabled medical devices in 2023, marking a significant increase in the validation of these technologies for clinical use.

Simultaneously, the proliferation of Genomic and Precision Medicine Testing Services is moving the diagnostic focus from broad screening to individualized patient profiling. Distinct from standard bioanalytical testing used for characterizing drug substances, this movement emphasizes the identification of hereditary risks and the direction of targeted therapies for specific patients, especially in prenatal care and oncology. In response, service providers are broadening their offerings to encompass advanced molecular diagnostics that provide profound clinical insights and enable personalized treatment strategies. This strong demand is reflected in recent financial performance; Quest Diagnostics, in its 'Fourth Quarter and Full Year 2023 Financial Results' from February 2024, announced double-digit revenue growth in its advanced clinical segments, particularly hereditary genetics and prenatal testing, highlighting the market's uptake of specialized precision testing.

Key Market Players

  • Eurofins Scientific (Ireland) Limited
  • Thermo Fisher Scientific Inc.
  • Microbac Laboratories, Inc.
  • ARL Bio Pharma, Inc.
  • EM Topco Limited
  • Intertek Group plc
  • Moderna, Inc.
  • ZYUS Life Sciences Corp
  • Alcami Corporation
  • F. Hoffmann-La Roche Ltd

Report Scope

In this report, the Global Healthcare Testing Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Healthcare Testing Services Market, By Service Type

  • Chemical Testing
  • Microbiological Testing
  • Toxicology Testing
  • Stability Testing
  • Others

Healthcare Testing Services Market, By Product Type

  • Anti-viral Drugs
  • HIV Drugs
  • Fertility Drugs
  • Anti-diabetic Drugs
  • Respiratory Drugs
  • Anticoagulants
  • Medical Devices
  • Pharmaceutical Packaging
  • Others

Healthcare Testing Services Market, By Development Stage

  • Preclinical
  • Clinical
  • Manufacturing

Healthcare Testing Services Market, By End User

  • Pharmaceutical Industry
  • Contract Research Organization
  • Others

Healthcare Testing Services Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Healthcare Testing Services Market.

Available Customizations:

Global Healthcare Testing Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Healthcare Testing Services Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service Type (Chemical Testing, Microbiological Testing, Toxicology Testing, Stability Testing, Others)
    • 5.2.2. By Product Type (Anti-viral Drugs, HIV Drugs, Fertility Drugs, Anti-diabetic Drugs, Respiratory Drugs, Anticoagulants, Medical Devices, Pharmaceutical Packaging, Others)
    • 5.2.3. By Development Stage (Preclinical, Clinical, Manufacturing)
    • 5.2.4. By End User (Pharmaceutical Industry, Contract Research Organization, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Healthcare Testing Services Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service Type
    • 6.2.2. By Product Type
    • 6.2.3. By Development Stage
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Healthcare Testing Services Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service Type
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Development Stage
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Healthcare Testing Services Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service Type
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Development Stage
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Healthcare Testing Services Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service Type
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Development Stage
        • 6.3.3.2.4. By End User

7. Europe Healthcare Testing Services Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service Type
    • 7.2.2. By Product Type
    • 7.2.3. By Development Stage
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Healthcare Testing Services Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service Type
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Development Stage
        • 7.3.1.2.4. By End User
    • 7.3.2. France Healthcare Testing Services Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service Type
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Development Stage
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Healthcare Testing Services Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service Type
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Development Stage
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Healthcare Testing Services Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service Type
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Development Stage
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Healthcare Testing Services Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service Type
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Development Stage
        • 7.3.5.2.4. By End User

8. Asia Pacific Healthcare Testing Services Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service Type
    • 8.2.2. By Product Type
    • 8.2.3. By Development Stage
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Healthcare Testing Services Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service Type
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Development Stage
        • 8.3.1.2.4. By End User
    • 8.3.2. India Healthcare Testing Services Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service Type
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Development Stage
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Healthcare Testing Services Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service Type
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Development Stage
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Healthcare Testing Services Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service Type
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Development Stage
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Healthcare Testing Services Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service Type
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Development Stage
        • 8.3.5.2.4. By End User

9. Middle East & Africa Healthcare Testing Services Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service Type
    • 9.2.2. By Product Type
    • 9.2.3. By Development Stage
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Healthcare Testing Services Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service Type
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Development Stage
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Healthcare Testing Services Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service Type
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Development Stage
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Healthcare Testing Services Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service Type
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Development Stage
        • 9.3.3.2.4. By End User

10. South America Healthcare Testing Services Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service Type
    • 10.2.2. By Product Type
    • 10.2.3. By Development Stage
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Healthcare Testing Services Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service Type
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Development Stage
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Healthcare Testing Services Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service Type
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Development Stage
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Healthcare Testing Services Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service Type
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Development Stage
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Healthcare Testing Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eurofins Scientific (Ireland) Limited
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. Microbac Laboratories, Inc.
  • 15.4. ARL Bio Pharma, Inc.
  • 15.5. EM Topco Limited
  • 15.6. Intertek Group plc
  • 15.7. Moderna, Inc.
  • 15.8. ZYUS Life Sciences Corp
  • 15.9. Alcami Corporation
  • 15.10. F. Hoffmann-La Roche Ltd

16. Strategic Recommendations

17. About Us & Disclaimer